<br>Hyderabad-based Bharat Biotech has applied to the DGCI for permission to start Phase 1 and 2 trials of their nasal coronavirus vaccine, top sources privy to the development told IANS.
Clinical trials of the 'BBV154' - a novel adenovirus vectored, intranasal vaccine for coronavirus -- will be conducted at various locations. The vaccine will be a single-dose one.
The nasal vaccine is different from the two intramuscular vaccines which recently got approval, due to being non-invasive, needle-free, not requiring trained healthcare workers, eliminating needle-associated risks, and suitable for children and adults, having scalable manufacturing.
According to the firm, an intranasal vaccine stimulates a broad immune response at the site of infection, in the nasal mucosa, which is essential for blocking both infection and transmission of Covid-19.
The vaccine has demonstrated protective efficacy in mice and hamsters. Mice and hamsters immunised with its single dose conferred superior protection against SARS-CoV-2 challenge, "more so than one or two intramuscular immunisations of the same vaccine and dose".
"Thus, intranasal immunisation of ChAd-SARS-CoV-2-S can create an immune response in the nose, which is the point of entry for the virus, thereby protecting against disease, infection and transmission," Bharat Biotech said in a statement.
On January 3, two intramuscular vaccines - Bharat Biotech's Covaxin and Oxford-AstraZeneca's Covishield manufactured by Serum Institute of India - were approved for restricted emergency use. Both are two-dose vaccines.
While the full efficacy of Covaxin is yet to be determined, it was given go-ahead by the DCGI citing 'public interest'. Covaxin is an indigenously developed vaccine by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR).
(Aakanksha Khajuria can be contacted at firstname.lastname@example.org)
Are you an Ayurveda doctor? Download our App from Google PlayStore now!
Download NirogStreet App for Ayurveda Doctors. Discuss cases with other doctors, share insights and experiences, read research papers and case studies. Get Free Consultation 9625991603 | 9625991607 | 8595299366
New York, Jan 19 (IANS) Researchers have identified two drugs that are potent against acute myeloid leukemia (AML) when combined, but only weakly effective when used alone.The...
New Delhi, Jan 19 (IANS) Vaccine hesitancy amongst healthcare workers must end, medical expert and Niti Aayog member Dr V.K. Paul said on Tuesday, amidst heightened concerns o...
Mumbai, Jan 19 (IANS) In a major swoop, the Mumbai Police Crime Branch has busted a racket involving sale of fake sutures of pharma giant Johnson & Johnson Co and arrested fiv...
<br>Days after getting the Drugs Controller General of India's nod for restricted emergency use of India's first indigenously-made coronavirus vaccine, Bharat Biotech ha...